Public annual accounts

Dr. Langlois financials

Name: Dr. Langlois financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr. Langlois, with comparable measures and links to available source documents.

Company overview

Registry number

0889499403

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for Dr. Langlois

2025 versus 2024

Operating line: €476,052
EBITDA: €472,871
Total assets: €1,640,970
Equity: €1,593,163

EBITDA margin +99.3% · Equity ratio +97.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€476,052	€472,871	€1,640,970	€1,593,163	-
202431 Dec 2024	€408,683	€405,152	€1,474,790	€1,261,049	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report